Top Ad

Dexketoprofen + Tramadol tablets

Form: Tablets

Strength: 25 mg dexketoprofen + 37.5 mg tramadol

Reference Brands: Enantyum(EU)

Category: Analgesic

Dexketoprofen + Tramadol tablets are approved in the EU for managing moderate to severe acute pain, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, this combination is currently not approved or marketed. In the EU, regulatory approval requires comprehensive clinical data and pharmacovigilance plans. Both regions enforce strict prescribing regulations due to the opioid component. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for dexketoprofen + tramadol formulations, ensuring adherence to European standards for safe, effective analgesic therapy while navigating complex regulatory pathways effectively.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Paracetamol + Codeine tablets

Strength: 300 mg paracetamol + 30 mg codeine; 300 mg + 60 mg

Form: Tablets

Reference Brands: Tylenol with Codeine(US)

View More Get Enquiry
Aceclofenac + Paracetamol tablets

Strength: 100 mg Aceclofenac + 325 mg Paracetamol

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View More Get Enquiry
Tramadol + Paracetamol tablets

Strength: 37.5 mg tramadol + 325 mg paracetamol; 75 mg + 650 mg

Form: Oral Tablets

Reference Brands: Ultracet(US); Tramacet(EU)

View More Get Enquiry
Prilocaine + Lidocaine Creams and Ointments

Strength: 2.5%, 5%, 7% (prilocaine); 2.5% lidocaine

Form: Creams and Ointments

Reference Brands: EMLA, Oraqix, Ametop(US & EU)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.